MOSAIQ
mosaiq.tech
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Entrepreneurs Roundtable Accelerator
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 43%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Entrepreneurs Roundtable Accelerator Similar startupsby what they do, their industry and backers
Everything you own in one place. Catalog years of your purchases from thousands of brands and retailers with a simple sync.
Ettitude is the healthiest fabric you can buy. Sleep easy knowing you're wrapped up in something luxurious, better for you and better for…
Signals starts a personal, one-to-one conversation with every customer after delivery, helping them find what to buy next while giving them…
We maximize the value of your energy storage systems. Now and in the future.
Bemyfriends is here to transform the value of your fandom into a successful business.
Agentic AI pricing platform for mid-market retailers. Turn messy retail data into structured, explainable price decisions in days, not…
Overview
Mosaiq lets retailers turn the value of products customers already own into purchasing power for what they buy next.
News
AliveDx registers MosaiQ, its Instrument for Multiplex Testing of Autoimmune Diseases, Allergies and Beyond, as a Class II Exempt Device with the U.S. Food and Drug Administration (FDA)
/PRNewswire/ -- AliveDx, the global in-vitro diagnostics company dedicated to advancing patient care, today announced that its MosaiQ instrument is registered...
Read more
Report
AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex Celiac Disease (CD) multiplex microarray
AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex Celiac Disease (CD) microarray.
Read more
Report
AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex Celiac Disease (CD) multiplex microarray
Read more
Report
Quotient Limited Announces Receipt of U.S. FDA Emergency Use Authorization (EUA) for MosaiQ COVID-19 Antibody test
JERSEY, Channel Islands, Sept. 28, 2020-- Quotient Limited, headquartered in Eysins, Switzerland, today announced that on September 25, 2020, the U.S. Food and Drug Administration issued an Emergency Use Authorization for Quotient's COVID-19 antibody test
Read more
Report
Quotient Limited Provides an Update on Recent MosaiQ Milestone Achievements together with Third Quarter Fiscal 2020 Results
--Quotient Limited, a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, today re-capped recently disclosed milestone achievements which included the completion of a third party feasibility study of its innovative Molecular Diseas
Read more
Report
KLAS Oncology Report: Elekta
/PRNewswire/ -- Among oncology software products, customers ranked Elekta first for its MOSAIQ Oncology Information System (OIS) in a survey by KLAS, an...
Read more
Report